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Neuronal damage in autoimmune neuroinflammation
is the correlate for long-term disability in multiple
sclerosis (MS) patients. Here, we investigated the
role of immune cells in neuronal damage processes
in animal models of MS by monitoring experimental
autoimmune encephalomyelitis (EAE) by using two-
photon microscopy of living anaesthetized mice. In
the brainstem, we detected sustained interaction
between immune and neuronal cells, particularly
during disease peak. Direct interaction of myelin
oligodendrocyte glycoprotein (MOG)-specific Th17
and neuronal cells in demyelinating lesions was
associated with extensive axonal damage. By com-
bining confocal, electron, and intravital microscopy,
we showed that these contacts remarkably resem-
bled immune synapses or kinapses, albeit with the
absence of potential T cell receptor engagement.
Th17 cells induced severe, localized, and partially
reversible fluctuation in neuronal intracellular Ca2+
concentration as an early sign of neuronal damage.
These results highlight the central role of the Th17
cell effector phenotype for neuronal dysfunction in
chronic neuroinflammation.
INTRODUCTION
Although it is assumed that in autoimmune neuroinflammation
the primary immune response is directed against the myelin
sheath, axonal and neuronal injury are already prominent in early
disease stages and very likely determine the degree of long-term
disability in patients (Siffrin et al., 2010). Experimental autoim-
mune encephalomyelitis (EAE) is the prototype inflammatory
demyelinating disease of the central nervous system (CNS),
which serves as a model for the human disease multiple scle-424 Immunity 33, 424–436, September 24, 2010 ª2010 Elsevier Inc.rosis (MS). The pathologic correlate of the multifocal neurologic
deficit is the invasion of immune cells, predominantly T cells
and macrophages in the CNS, which attack the myelin sheath
and lead to disseminated plaque-like demyelination. Axonal
pathology has been demonstrated in biopsies from MS patients
(Ferguson et al., 1997; Trapp et al., 1998) and correlates with
disability (Bjartmar et al., 2000). In fact, the extent of axonal injury
correlates with the number of immune cells present in the lesions
(Kuhlmann et al., 2002). In addition to axonal pathology, damage
to and loss of neurons in both MS patients and EAE has
been demonstrated, particularly in the spinal cord (Peterson
et al., 2001; Vogt et al., 2009). A number of potential triggers of
neurodegeneration in inflammatory CNS disease have been
suggested, e.g., bystander damage caused by excitotoxicity,
reactive oxygen species, myelin breakdown products, or the
death ligand TRAIL (Ransohoff and Perry, 2009; Zipp and
Aktas, 2006). Other factors discussed as causes for axonal
and neuronal degeneration include the loss of myelin-derived
support and secondary disruption of axonal ion concentrations,
with ion channel reorganization processes in demyelinated
axons leading to energy failure (Trapp and Nave, 2008).
However, the actual events that take place in vivo remain largely
unknown. Here, we provide evidence that Th17 cells, which
other studies have already shown to be associated with clinical
deficit in EAE (Ivanov et al., 2006), form synapse-like contacts
with neurons and their processes and play a dominant role in
neuronal injury during disease course. Our data demonstrate
a direct interaction of Th17 cells with neurons and both reversible
and irreversible neuronal dysfunction induced by Th17 cells
in vivo in both axons and neuronal cell bodies.RESULTS
CNS-Specific Th17 Cells in EAE Exhibit Characteristic
Motility Changes
To investigate the role of immune-neuronal interaction in vivo by
two-photon laser scanning microscopy (TPLSM), we used mice
(B6.tdRFP/B6.Thy1.EGFP) with enhanced green fluorescent
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Figure 1. Immune Infiltrates in Demyelinating Lesions Are Highly Dynamic and Show Different Motility Patterna in Distinct Disease Stages
(A) Mean clinical scores (±SEM) of animals in active EAE in B6.tdRFP/B6.Thy1.EGFP.
(B) Mean clinical scores (±SEM) of 2d2.tdRFP Th17 cell-induced adoptive-transfer EAE in B6.Rag1/.Thy1.EGFPmice; preonset (gray), onset (red), peak (blue),
and chronic or remission (yellow).
(C) TPLSM of a representative brainstem lesion in the onset of EAE in B6.tdRFP/B6.Thy1.EGFP (green: EGFP, neuronal processes; red: CD45+.tdRFP cells)
(maximal intensity projection of a volume of 70 mm thickness and 36 planes, time point 0; see also Movie S1).
(D) Automated single-cell tracking of CD45+.tdRFP cells.
(E) TPLSM of a representative brainstem lesion in the onset of 2d2.tdRFP Th17 cells (red)-induced passive EAE in B6.Rag1/.Thy1.EGFP (Movie S2).
(F) Automated single-cell tracking of 2d2.tdRFP Th17 cells.
(G) Mean track velocity (±SEM) of 2d2.tdRFP Th17 cells in adoptive transfer EAE: onset: 6.30 ± 0.1 mm/min, n = 680; peak: 5.02 ± 0.1 mm/min, n = 1167; chronic
disease phase 5.36 ± 0.1 mm/min, n = 708. The mean track velocity of CD45+.tdRFP cells in active EAE is as follows: onset: 4.6 ± 0.15 mm/min, n = 326; peak:
4.51 ± 0.15 mm/min, n = 377; chronic phase: 4.97 ± 0.1 mm/min, n = 569; remission: 6.18 ± 0.2 mm/min, n = 271.
(H) Mean displacement rate (±SEM) of 2d2.tdRFP Th17 cells is as follows: onset: 3.20 ± 0.1 mm/min, peak: 2.07 ± 0.1 mm/min, chronic: 2.31 ± 0.1 mm/min;
***p < 0.0001 between onset and peak/onset and chronic, p < 0.0001.
(I) Themeandering index (mean ± SEM) of 2d2.tdRFP Th17 cells is as follows: onset: 0.50 ± 0.1 mm/min, peak: 0.43 ± 0.1 mm/min and chronic: 0.39 ± 0.01 mm/min;
p < 0.0001 between onset and peak; onset and chronic, p < 0.05.
(***p < 0.0001; Kruskal-Wallis-Test, post test: Dunn’s Multiple Comparison Test; at least three independent experiments per disease stage).
Immunity
Th17 Cell-Induced Neuronal Dysfunctionprotein (EGFP) expression in neurons and neuronal processes
(axons and dendrites) and red fluorescent protein (tdRFP)
expression in bone marrow-derived peripheral immune cells.
We actively induced EAE in B6.tdRFP/B6.Thy1.EGFP byImsubcutaneous immunization with myelin oligodendrocyte glyco-
protein (MOG35-55) and performed TPLSM of brainstem lesions
in these mice in different phases of the disease (Figure 1A
and Figure S1A available online). To specifically address themunity 33, 424–436, September 24, 2010 ª2010 Elsevier Inc. 425
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Figure 2. The Interaction of 2d2.tdRFP Th17, OT-2.tdRFP Th17, and 2d2.tdRFP Th1 Cells with Neuronal Pathology
Time-lapse TPLSM of in vitro differentiated Th17 and Th1 cells, which had been co-transferred on day 7 into 2d2 Th17 cell-induced passive EAE in
B6.Rag1/.Thy1.EGFP mice.
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Immunity
Th17 Cell-Induced Neuronal Dysfunctionrole of encephalitogenic CD4+ T cells in the context of CNS
damage processes, we used an adoptive transfer model of
MOG35-55-specific (2d2) and red-fluorescent (tdRFP) in vitro
Th17 cell-differentiated 2d2.tdRFP Th17 cells (Figures S1C–
S1E), which were injected into (nonirradiated) B6.Rag1/.
Thy1.EGFP mice and which induced a severe, nonremitting
passive EAE (Figure 1B and Figure S1B). Two-photon imaging
was performed in anaesthetized mice, which were continuously
monitored for vital signs. At the onset of the clinical disease,
inflammatory EAE lesions in the brainstem exhibited typical peri-
vascular accumulation of immune cells, but also large-scale
tissue infiltration and interactions of immune cells with neuronal
processes (Figure 1C and Movie S1). Automated cell tracking
revealed the highly dynamic and tissue-invasive nature of the
CD45+.tdRFP immune cells in active EAE lesions (Figure 1D)
and of encephalitogenic 2d2.tdRFP Th17 cells in adoptive trans-
fer EAE (Figures 1E and 1F; Movie S2). Quantitative analyses of
the immune dynamics of 2d2.tdRFP Th17 cells demonstrated
a differential motility pattern in different disease phases.
2d2.tdRFP Th17 cells slowed down with clinical worsening and
disease progression (Figure 1G) to reduced mean velocities in
the peak and chronic disease phase. CD45+.tdRFP in active
EAE showed very similar mean velocities in all disease stages
with the exception of the remission phase. Remission was distin-
guished from the chronic phase by a recovery of velocity. In line
with these findings, 2d2.tdRFP Th17 cells showed a substantial
reduction of displacement rates in the peak and chronic phase
(Figure 1H), which correlates with higher confinement of enceph-
alitogenic T cells as shown by meandering index in correlation
with clinical disease (Figures 1B and 1I). Similar motility changes
have been described forDO11.10 TCR transgenic CD4+ T cells in
lymph nodes and myelin basic protein (MBP)-specific and oval-
bumin (OVA)-specific CD4+ T cells in the spinal cord. In these
studies, the motility changes were found to depend on antigen
presence, which has accordingly been interpreted as a stop
signal in the process of antigen recognition (Miller et al., 2002;
Kawakami et al., 2005; Odoardi et al., 2007). Taken together,
these results indicate that motility changes of CNS-specific
CD4+ T cells in particular correlate with the progression and
severity of the clinical disease in EAE.(A) Automated tracking of 2d2.tdRFP Th17 cells shown as a connecting line of th
(B) Automated tracking of 2d2.tdRFP Th1 cells (red) show less pronounced tissu
(C) OT-2.tdRFP Th17 cells enter the CNS lesions similarly as 2d2.tdRFP Th17 ce
(D and E) Quantitative cell tracking analysis shows that all Th17 T cell population
velocity and displacement rate than 2d2.tdRFP Th1 cells. Themean displacement
Th17 cells (3.10 mm/min) and OT-2.tdRFP Th17 cells (4.53 mm/min).
(F) Meandering indexes (mean ± SEM) differ slightly in all cell groups with no clear
Test (**p% 0.01, ***p% 0.0001) were used; pooled data of at least two indepen
(G) Contact formation (white, colocalization channel) of 2d2.tdRFP Th17 cells (red
(Movie S3).
(H) Contact formation of cotransferred OT-2.tdRFP Th17 cells in B6.Rag1/.Thy
2d2.tdRFP Th17 cells with static (indicated by an arrowhead, rounded OT-2.tdR
arrow, scanning OT-2.tdRFP Th17 cell; Movie S4).
(I) Comparison of contact index k (mean ± SEM) showed significant lower probab
cells, IL-17A-MACS-enriched 2d2.tdRFP Th17 cells and 2d2.tdRFP Th17 cells (**
(J) Automated tracking of 3D-rendered contacts (mean ± SEM) in 2d2.tdRFP Th
increase of nonrandom, long-lasting interaction at the peak and chronic phase
5 min duration; white) and long-lasting contacts (equal or longer than 5 min duratio
and dynamic interactions (velocity equal/higher than 2.4mm/min; gray).
ImImmune-Neuronal Interaction Is a Key Feature beyond
Conventional Antigen-Dependent Motility Changes
To specifically analyze the interactions of immune cells with
neurons and their processes that were observed in our experi-
ments, we cotransferred CNS antigen-specific (2d2.tdRFP)
andnon-CNSantigen-specific (ovalbumin-specific,OT-2.tdRFP)
CD4+ T cells 7 days after induction of passive EAE in
B6.Rag1/.Thy1.EGFP, which had been induced for EAE by
nonfluorescent 2d2 Th17 cells. To investigate the impact of the
differentiation status of cotransferred T cells on the interactive
behavior, we compared 2d2.tdRFP Th17 (Figure 2A), IL-17A-
enriched 2d2.tdRFP Th17, 2d2.tdRFP Th1 cells (Figure 2B), and
OT-2.tdRFP Th17 cells (Figure 2C; cytokine secretion pattern
and gene expression pattern of T cell subsets; see Figures
S2A–S2D).
Here, we saw similar motility characteristics of 2d2.tdRFP
Th17 cells, IL-17A-enriched 2d2.tdRFP Th17 cells, and OT-
2.tdRFP Th17 cells, all of which differed from 2d2.tdRFP Th1
cells by higher mean velocity (Figure 2D) and displacement
rate (Figure 2E), whereas meandering indexes varied nonspecif-
ically (Figure 2F). These increases in the motility parameters
coincided with a higher interaction rate with the neuronal
compartment (Figure 2G). The interactions were mainly of
a dynamic kind with Th17 cells scanning axons especially in
areas of axonal dysmorphology (Movie S3), e.g., axonal varicos-
ities and ellipsoid bodies, which are signs of a (partially
reversible) block of axonal transport (Coleman, 2005). This
demonstrates that 2d2.tdRFP Th17 cells engage in further inter-
actions beyond the classic motility changes upon antigen recog-
nition. Interestingly, within the CNS tissue, for the OT-2.tdRFP
Th17 cells, there were similar interaction patterns with neuronal
pathology (Figure 2H and Movie S4) as for the 2d2.tdRFP Th17
cells. The OT-2.tdRFP Th17 cell-neuronal interaction was simi-
larly localized along dysmorphic axons. We exploited the fact
of nonoverlapping spectra of EGFP and tdRFP fluorescence to
measure the extent of contact formation of the different T cell
subsets. We quantified the area of contact formation (voxels
positive for green and red fluorescence only in areas of close
proximity; Figures S3A and S3B) and in order to circumvent
the bias due to variation of cell numbers (both immune ande preceding 20 time-lapse positions in EAE lesions in peak disease.
e invasive migration paths.
lls.
s (including MACS enriched 2d2.tdRFP Th17 cells) exhibit a higher mean track
rate (± SEM) for 2d2.tdRFP Th1 cells (2.77 mm/min) is lower than for 2d2.tdRFP
subset specificity. Kruskal-Wallis Test, post-test: Dunn’s Multiple Comparison
dent experiments (at least three imaging fields each) are presented.
) at neuronal process varicosities (blue, dotted area) in B6.Rag1/.Thy1.EGFP
1.EGFP (Movie S4). Interaction with neuronal pathology in a similar manner as
FP Th17 cell contacts axonal swelling) and dynamic contacts (indicated by an
ility for 2d2.tdRFP Th1 cells to contact neurons compared to OT-2.tdRFP Th17
*p% 0.0001; Kruskal-Wallis Test, post-test Dunn’s Multiple Comparison Test).
17-induced adoptive transfer EAE in B6.Rag1/.Thy1.EGFP mice reveals an
s of the disease. Interaction patterns were differentiated into short (less than
n), which were subdivided into static (velocity of lower than 2.4 mm/min; black)
munity 33, 424–436, September 24, 2010 ª2010 Elsevier Inc. 427
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Figure 3. Confocal and Electron Micro-
scopic Analysis of Brainstem EAE Lesions
(A) Confocal microscopy of representative pontine
EAE lesion in adoptive transfer EAE specimen of
B6.Rag1/.Thy1.EGFP. CD4+ T cells (magenta,
anti-CD4); neurons/neuronal processes (green,
Thy1.EGFP); MHC-II+ cells (blue); insert: magnifi-
cation.
(B) Confocal microscopy of representative tissue
samples from OT-2 co-transfer animals. OT-
2.tdRFPTh17cells (red), neuronalprocesses (green,
Thy1.EGFP), Hoechst (blue); insert: magenta,
anti-CD4.
(C) Electron microscopy of representative
2d2.tdRFP Th17 cell-induced EAE lesion: CD4+
T cell, neurophil (longitudinal and cross sectioned
neuritis); neuronal protrusions (asterisk) with
bulked and reduced myelin sheaths.
(D) Magnification of boxed area in (C) reveals
accumulation of mitochondria, endoplasmic retic-
ulum, numerous vesicles (arrowheads). The con-
tacted neurite (arrow) has vacuolic cytoplasm
and also a diffuse margin without myelin.
(E) Electron microscopy of a representative active
EAE lesion (left panel, insert: semithin section);
a CD4+ T cell (membrane staining) directly
contacts a pontine neuron with intense basophilic
cytoplasm as a sign of degeneration (indicates
degradation of nucleus proteins/DNA). A myelin-
ated axon (arrow) and an axosomatic synapse
(marked by an asterisk).
(F) Magnification of boxed area in (E): synaptic
cleft and presynaptic density (marked by arrow-
heads) are also involved; membrane protrusion
(open arrow) as an indication of beginning degra-
dation (‘‘blebbing’’). Scale bars represent 2 mm
(left panel) and 500 nm (right panel).
Immunity
Th17 Cell-Induced Neuronal Dysfunctionneuronal), we computed a contact index k, derived by applying
the law of mass action, which objectifies the probability of
tdRFP-positive and EGFP-positive cell populations engaging
in close contact formation irrespective of the actual cell
numbers (Figures S3C) and correlated with disease severity
(Figure S3D). During the peak of EAE, the contact index k of
2d2.tdRFP Th17 cells (k = 4.98; SEM 0.22), IL-17+ 2d2.tdRFP
Th17 cells (k = 3.9; SEM 0.92), and OT-2.tdRFP Th17 cells
(k = 3.85; SEM 0.35) was highly increased compared to
2d2.tdRFP Th1 cells (k = 1.82; SEM 0.10), which indicates that
immune-neuronal interaction is a feature predominantly found
in the Th17 cell subset (Figure 2I). To identify random, short428 Immunity 33, 424–436, September 24, 2010 ª2010 Elsevier Inc.contacts that might be the consequence
of nondirected immune cell motility, we
also quantified the dynamics of immune-
neuronal interaction by automated track-
ing of the established contacts (colocali-
zation area). For discriminating short or
transient (random) contacts from long-
lasting (most probably nonrandom) inter-
actions, Th17 cells exposed a distinct
contact pattern compared to Th1 cells
with increased numbers of sustained
interactions, especially at the peak ofthe disease (Figure 2J). Th1 cells were found to form predomi-
nantly random, nonspecific, and short contacts, which also
correlates with the lower contact index of 2d2.tdRFP Th1 cells.
Thus the differentiation status of CD4+ T cells influences their
capability to interact with the neuronal compartment.
Th17 Cells Directly Contact Neurons Irrespective
of Their CNS-Antigen Specificity
Confocal analysis of fixed tissue samples of cotransfer
B6.Rag1/.Thy1.EGFP EAE mice proved colocalization of
both 2d2.tdRFPTh17cells (Figure 3A;MovieS5) andOT-2.tdRFP
Th17 cells with axonal pathology (Figure 3B). To exclude the
Immunity
Th17 Cell-Induced Neuronal Dysfunctioninvolvement of macrophages and microglia, which are not fluo-
rescent in B6.Rag1/.Thy1.EGFP, we stained CD4 (magenta)
and MHC-II (blue) (Figure 3A). Here, CD4+ T cells could be colo-
calized in vessel cuffs with MHC-II-expressing cells (Figure 3A,
arrow), whereas CD4+ T cells within the CNS tissue colocalized
with neuronal processes without proximity to MHC-II expressing
cells (Figure 3A, insert). As expected, we did not detect MHC-II
expression on neurons or axons in demyelinating lesions, which
is in line with previous reports (Hickey and Kimura, 1988; Lamp-
son and Hickey, 1986). Electron microscopic examination
confirmed immediate proximity of CD4+ T cells to neuropil (Fig-
ure 3C), here consisting of longitudinal and cross-sectioned
neurites with mostly distended and reduced myelin sheathes.
Within the cytoplasm of the CD4+ T cells, accumulation of mito-
chondria, endoplasmic reticulum, and numerous coated vesicles
(Figure 3D, arrowheads) indicated a clear synapseor kinapse-like
structural polarization toward compromised neurites. In addition,
we observed T cells directly contacting neuronal cell bodies
(Figures 3E and 3F), DAB+ CD4+ T cells in close proximity to
a neuronal soma, extending a probing process (asterisk) into
the (nonmyelinated) presynaptic terminal of an axo-somatic
synapse (arrowhead); such a finding indicates communication
between T cells and neurons along the whole neuron and not
only at the site of demyelination. This indicates that CD4+
T cells contact neurons and their processes in EAE, independent
of MHC-II expression or antigen-specificity and also in the
absence of myelination.
Th17 Cells Establish Immune-Neuronal Synapses
and Induce Neuronal Cell Death In Vitro
To further investigate the in vivo evidence of CD4+ T cell-
neuronal synapse formation and its impact on the neuron, we
tested various in vitro differentiated CD4+ T cell phenotypes for
their potential to induce neuronal damage in cultured hippo-
campal neurons (Figure 4A). Indeed, Th17 cells formed synapses
(Figures S4A and S4B), induced substantial neuronal cell
death (Figure 4B) and reduced the number of NeuN+ cells
(Figure 4C), whereas Th0 and Th1 cells did not. Interestingly,
supernatant from Th17 cell cultures did not reduce the number
of NeuN+ cells, which underlines the importance of contact
formation for the neuronal damage mechanism. Next, we
addressed how these 2d2.tdRFP Th17 cell contacts with
cultured neurons compare with immune synapses (ISs). This
was done by analyzing characteristic IS molecules. During
cognate interactions of APCs with T lymphocytes in ISs, the
T cell microtubular cytoskeleton is rearranged, which leads to
a reorientation of the microtubule-organizing center (MTOC)
toward the vicinity of the APC-T cell contact area (Dustin and
Colman, 2002). To determine whether neurons can induce
such cytoskeletal rearrangements during neuron-T cell interac-
tions, we triple-stained Th17 cell-neuronal cocultures for
a-tubulin, Hoechst, and CD4 to identify the MTOC and to mark
cell nuclei and CD4+ T cells, respectively (Figure 4D and
Figure S4C). Cocultured neurons indeed induced T cell MTOC
translocation toward the contact zone (Figure 4D, insert), which
equals the findings in EAE (see Figures 3C and 3D). Next, we
excluded any MHC-II relevance for this phenomenon by investi-
gating MHC-II deficient neurons (H2Ab1-Ea/)—the MHC-II
deficiency also applies to the infrequent contaminating glialImcells—which demonstrated similar neuronal cell death induction
as WT neurons upon coculture with 2d2.tdRFP Th17 cells
(Figure 4E). To confirm that similar processes were induced in
CD4+ T cells as in IS formation albeit in the absence of antigen
presentation, we next investigated an essential IS molecule,
the adhesion molecule LFA-1 (CD18), which typically clusters
in ISs as a ring at the target contact site. This ring of LFA-1 clus-
ters is situated in the so-called peripheral supramolecular
activation clusters (pSMACs) and confines the polarized
MTOC (Kuhn and Poenie, 2002). Productive LFA-1 ligation has
been shown to be indispensable for efficient targeting of
granules to the interface (Anikeeva et al., 2005), and indeed in
our system, the use of Itgal/ (LFA-1-deficient) Th17 cells
reduced the cell death of neurons markedly to the degree seen
in control Th1 and Th0 cell cocultures (Figure 4E); such a finding
emphasizes the importance of a functional immune-neuronal
synapse formation by these Th17 cells for the induction of cell
death.
Th17 Cell-Neuronal Interaction Leads to Neuronal
Dysfunction as Shown by Sustained Ca2+ Elevation
In order to analyze the early functional outcome of immune-
neuronal synapse formation on the affected axons and neuronal
somata in vivo, we performed fluorescence resonance energy
transfer (FRET)-TPLSM in B6.Thy1.CertnL15 (Figure 5A), which
carry a Troponin C-based genetically encoded Ca2+ sensor in
neurons (Heim et al., 2007) and which had been induced for
EAE by adoptive transfer of 2d2.tdRFP Th17 cells. The mean
Citrine/Cerulean ratio (YFP/CFP) was used for the generation
of an intensity-modulated ratio channel, which encodes for intra-
cellular Ca2+ increase (Figures 5B and 5C and Movies S6 and
S7). In EAE lesions, the contact of 2d2.tdRFP Th17 cells with
neuronal processes was associated with localized high Ca2+,
which was a frequent issue (Figure 5B) andwhich was also found
for CD45+.tdRFP in B6.tdRFP/B6.Thy1.EGFP (Figure S5A).
2d2.tdRFP Th17 cell contact also led to Ca2+ increase in the
nonmyelinated neuronal cell body and was associated with
localized Ca2+ oscillations in the attacked neurons (Figure 5C;
Movie S7). Critical Ca2+ concentrations (Figures S5B and S5C)
were predominantly reached in areas of sustained immune-
neuronal contact formation (Figure 5D, normalized to the
maximum Ca2+ increase upon 300mM K+Cl application).
Cotransfer of OT-2.tdRFP Th17 cells into B6.Thy1.CertnL15,
which had been induced for EAE by subcutaneous immunization
with MOG35-55, also induced contact-dependent Ca
2+ distur-
bances—though presumably slightly lower—in neurons and
their processes (Figures 5E and 5F). Thus, Ca2+ disturbances
in neurons and their processes are a frequent finding upon
contact formation between immune and neuronal cells.
Th17 Cell-Induced Ca2+ Increase Precedes Irreversible
Axonal and Neuronal Injury
Next, we investigated whether the FRET-TPLSMmeasured Ca2+
increase progressed to evident neuronal damage. Time-lapse
imaging revealed that sustained immune-mediated Ca2+ eleva-
tion indeed preceded axonal dissection at the site of immune-
neuronal contact formation (Figure 6A; Movie S8). Most impor-
tantly, long-lasting Ca2+ increase in neuronal somata could be
related to irreversible damage as shown by integration ofmunity 33, 424–436, September 24, 2010 ª2010 Elsevier Inc. 429
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Figure 4. Th17 Cells Establish Immune-Neuronal Synapses and Induce Neuronal Cell Death In Vitro
(A) In vitro-differentiated 2d2 Th0, Th1, and Th17 and OT-2 Th17 cells were cocultured with E17-hippocampal neurons (1:1 ratio) and stained for TUNEL (red) and
NeuN (green) after 24 hr of coculture.
(B) Quantification of TUNEL fluorescence intensity normalized to 2d2 Th17 cell coculture levels: 2d2 Th0: 38.9% ± 1% (mean, SD; p = 0.029, t test); 2d2 Th1:
44.4% ± 24.3%, OT-2 Th17 207.4% ± 42.5% (p = 0.005 compared to 2d2 Th0 cells).
(C) Quantification of NeuN+ cells normalized to Th0 cell co-culture numbers: 2d2 Th17 cells: 44.1%, SD = 10.7% (p < 0.0001); OT-2 Th17 cells: 43.3%,
SD = 10.1% (p < 0.0001), 2d2 Th1 cell co-cultures 87.4, SD = 3.7%; Th17 cell supernatant: 103%, SD = 9.2%). CD4+ T cell numbers were unaltered in all groups
after coculture.
(D) Confocal microscopy of 2d2 Th17 cell-neuronal coculture (red, a-tubulin; green, anti-CD4; blue, Hoechst): aggregation of a-tubulin in 2d2 Th17 cells at the site
of contact formation between CD4+ T cell and neuronal process (inset, a-tubulin only).
(E) Quantification of TUNEL fluorescence signal (normalized to Th17 cell-neuronal coculture levels): similar cell death rates in wild-type versus MHC-II-deficient
(H2Ab1-Ea/) neurons (mean = 103%, SD = 12.7%) and reduced cell death induction in the absence of LFA-1 on Th17 cells (Itgal/ Th17 cells; mean = 66.7%,
SD = 7.4%, p < 0.001).
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Th17 Cell-Induced Neuronal Dysfunctionpropidium iodide into the nucleus of these neurons (Figure 6B).
Thus, Ca2+ elevation as measured by FRET-TPLSM is a valid
marker for early neuronal damage.
Interestingly, the largest extent of Ca2+ increase was
measured at the border of active demyelinating lesions that
showed signs of disintegrating myelin sheaths and myelin debris
(Figure 6C; Figure S6A) and is reminiscent of findings in MS
pathology that show a clear correlation between immune cell
presence and axonal APP accumulation as early histopathologic
sign of neuronal damage (Kuhlmann et al., 2002). To quantify
the dimension of acute axonal damage in 2d2.tdRFP Th17
cell-induced B6.Rag1/.Thy1.EGFP EAE and active EAE in
B6.tdRFP/B6.Thy1.EGFP, we analyzed the extent of remaining430 Immunity 33, 424–436, September 24, 2010 ª2010 Elsevier Inc.GFP-positive voxels in the EAE lesions, which correlates with
neuronal cell density (Bannerman et al., 2005). There was a
substantial decrease of remaining neuronal tissue as defined
by GFP loss, which indicates stronger neurodegeneration in
the presence of 2d2 Th17 cell (Figures 6D and 6E). These find-
ings were supported by the analysis of respective score-
matched brainstem specimens (Figure 6F; Figure S6B) stained
for the amyloid precursor protein (APP), which has been shown
to accumulate in axons with intra-axonal transport block
(Coleman, 2005). Furthermore, the transfer of 2d2 Th17 cells
tended to promote a nonremitting andmore progressive disease
in actively immunized C57BL/6 mice compared to 2d2 Th1 cell-
transferred control animals (Figure 6G). This clinical effect of
0 5 10 15 20 25 30
0
5
10
15
20
25
30
35
40
45
50
 Soma
 Axon
ΔR
/R
 [%
]
Time (min)
Ca2+-signal OT-2
Ca2+-signal 2d2
0 2 4 6 8 10 12 14 16 18
0
10
20
30
40
50
60
70
80 Soma
 Axon
ΔR
/R
 [%
]
Time (min)
BA
E
D
F
C
C
Figure 5. Th17 Cells Induce Ca2+ Dynamics in Neurons upon Contact Formation In Vivo
(A) FRET-TPLSM of EAE lesions in 2d2.tdRFP Th17 cells (red) induced EAE in B6.Thy1.CertnL15 mice (Thy1 promotor driven Troponin-C-based, genetically en-
coded Ca2+ sensor). Ca2+ dynamics are registered by computing the ratio of Citrine (YFP, yellow) emission and Cerulean (CFP, blue) emission.
(B) Axonal time-lapse FRET-TPLSM shown as intensity-modulated channels of highlighted areas in (A), intensity-color-coded (scale: blue = low, red = high). High
intensity was reproducibly associated with close immune-axonal contacts (arrow). 2d2.tdRFP Th17 cells (green) are shown; representative examples of five inde-
pendent experiments (at least two imaging fields; measurements of at least three neurons or axons each) are shown.
(C) Neuronal time-lapse FRET-TPLSM shown as intensity-modulated channels of highlighted areas.
(D) Interactions of 2d2.tdRFP Th17 cells with neurons (arrow in B) and axonal processes (arrow in C) lead to oscillating Ca2+ increases, which temporarily or
permanently exceed the critical threshold of 45% DR/R (relative Ca2+ compared to K+Cl, see also Figures S5B and S5C).
(E) Cotransferred OT-2.tdRFP Th17 cells into active EAE in B6.Thy1.CertnL15 induce Ca2+ dynamics in neurons and their processes upon contact formation. The
left panel shows OT-2.tdRFP Th17 cells (red) infiltrate the neuronal nuclear area (yellow, YFP; blue, CFP) in brainstem EAE lesions. Right panel shows time-lapse
of Ca2+ increases as intensity-modulated ratio channel (YFP/CFP, scale color-intensity).
(F) Interactions of OT-2.tdRFP Th17 cells with neurons and axonal processes (arrows in E) lead to oscillating Ca2+ increases, which temporarily exceed the critical
threshold of 45% DR/R. Representative examples of two independent experiments (at least two imaging fields; measurements of at least three neurons/axons
each) are shown.
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weeks, could not be seen upon cotransfer of OT-2 Th17 cells
versusOT-2 Th1 cells (data not shown). Taken together, our find-
ings show that immune-mediated Ca2+ disturbances in neurons
and their processes as measured by FRET-TPLSM are an early
sign of neuronal dysfunction that can progress to irreversible
neuronal damage.
Immune-Mediated Ca2+ Oscillations Are Partially
Reversible by NMDA Receptor Blockade
Next, we wanted to know which mechanisms were responsible
for the observed neuronal dysfunction with Ca2+ changes in
EAE. One of the potential processes involved in T cell-induced
neuronal damage is glutamate-mediated excitotoxicity (Zipp
and Aktas, 2006)—as has been shown in various neurodegener-
ative diseases (Lipton and Rosenberg, 1994)—and indeed, we
found that T cells produce important amounts of glutamateIm(Figure S7A) and might be able by synapse formation to target
these molecules to neurons. To test this hypothesis in vivo, we
blocked N-methyl D-aspartate (NMDA) receptors by local appli-
cation of 300 mM (MK-801) 5-methyl-10,11-dihydro-5H-dibenzo
[a,d]cyclohepten-5,10-imine maleate (Murphy et al., 2008),
which has been successfully used in EAE (Bolton and Paul,
1997) and was effective in our in vitro coculture model
(Figure S7B). We compared the Ca2+ signal of axonal structures
(Figure 7A) with long-lasting contacts (areas 2 and 3) and one
with no visible contact (area 1) before and after the application
of MK-801. The axons without T cell contact maintained low
Ca2+ concentrations throughout the observation (Figure 7B),
whereas the axons with T cell contact exhibited Ca2+ oscillations
(Figures 7C and 7D). In the latter axons, we observed both an
immediate response to MK-801 application with a nearly
complete return of Ca2+ to baseline levels (Figure 7E) and no
change in others (Figure 7D), which exceeded a threshold ofmunity 33, 424–436, September 24, 2010 ª2010 Elsevier Inc. 431
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Figure 6. Th17 Cell-Induced Ca2+ Dynamics Correlate with Subsequent Morphologic Signs of Neuronal Damage
(A) Time-lapse FRET-TPLSM of EAE lesions in B6.tdRFP/B6.Thy1.CertnL15 shows that immune-neuronal contact areas (CD45+.tdRFP cells; green, axons, red)
with sustained localized Ca2+ increase (intensity modulated ratio channel, color-coded) can lead to axonal dissection nearby (indicated by arrows; scale bar
represents 20 mm), but may also be reversible (indicated by an arrowhead).
(B) Local application of propidium iodide (PI, left panel) at the end of FRET-TPLSM shows a correlation for sustained Ca2+ increase (right panel, intensity modu-
lated ratio channel, color-coded) in neuronal somata with PI inclusion in the nucleus as sign of irreversible neuronal damage.
(C) Local application of nile red (myelin staining, left panel) during FRET-TPLSM shows a correlation of highest Ca2+ increases (right panel, intensity modulated
ratio channel, color-coded) in areas of active demyelination.
(D) Comparison of loss of axons quantified by reduction of GFP positive voxels (as measured by intravital TPLSM) in EAE lesions of B6.tdRFP/B6.Thy1.EGFP
and 2d2.tdRFP Th17 cell-induced EAE lesions in B6.Rag1/.Thy1.EGFP.
(E) Quantification of axonal loss as defined in (D); in active EAE in B6.tdRFP/B6.Thy1.EGFP, the number of EGFP positive voxels is whereas in 2d2.tdRFP
Th17/B6.Rag1/.Thy1.EGFP is (mean, SEM; p = 0.0016, Mann-Whitney-U-Test; data from >3 independent experiments).
(F) Histopathologic analysis of acute neuronal damage by quantification of APP (DAB, arrow) of inflammatory brainstem lesions in 2d2 Th17 cell-induced passive
EAE (mean, SEM; n = 2 animals) versus active B6.tdRFP/B6.Thy1.EGFP EAE (n = 4 animals; p < 0.001).
(G) 7.53 106 2d2 Th1 versus 7.53 106 2d2 Th17 cells were cotransferred on day 12 (after onset of clinical signs) into C57BL/6 mice, which had been induced for
active EAE by subcutaneous immunization with MOG peptide. Animals were observed for 50 days for the development or remission of clinical signs (mean, SEM;
pooled data from two independent experiments).
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Th17 Cell-Induced Neuronal Dysfunction45% of maximal K+Cl responses. Semiquantitative Ca2+
amount evaluation of the axons in the whole imaging field
revealed that large-scale reversibility of axonal Ca2+ increase432 Immunity 33, 424–436, September 24, 2010 ª2010 Elsevier Inc.can be achieved in both EAE models investigated here.
In 2d2.tdRFP Th17 cell-induced EAE lesions, 59.34% of
Ca2+ increase could be reverted by application of MK-801
area 2
area 1
area 3
F
BA
C
area 1
area 2
area 3
E
0 20 40 60 80 100 120
0
10
20
30
40
50
60
70
ΔR
/R
 (%
)
Time (min)
 area 1
 area 2
 area 3MK 801
 Irreversible
 Reversible
B6.tdRFP->B6.Thy1.CertnL15
0
20
40
60
80
100
V 
%
 o
f C
a2
+  r
es
po
ns
e 
in 
ax
on
s
MK-801 PHT-
0
10
20
30
40
50
60
70
80
90
100
V 
%
 o
f C
a2+  
re
sp
on
se
 in
 a
xo
ns
 Irreversible
 Reversible
2d2.tdRFP Th17->B6.Thy1.CertnL15
MK-801-
G
D
MK-801
30 min 80 min
80 min
80 min
30 min
30 min
120 min
120 min
120 min
PHT
Figure 7. Immune-Mediated Ca2+ Oscillations Can be Partially Reverted by Pharmacologic Blockade of Glutamate Receptors and Na+
Channels
(A) TPLSMof EAE lesions in B6.tdRFP/B6.Thy1.CertnL15, CD45+.tdRFP (red), axons (yellow, YFP), andCa2+ dynamics (intensitymodulated ratio channel, gray-
scale). Morphological intact axons (area 1 [lowCa2+] and areas 2 and 3 [high Ca2+]) weremonitored over 120min. Local application of MK-801 (300 mMsolution for
30 min) was performed after an initial baseline monitoring time of 30 min. Immune cell motility was not altered by MK-801 (data not shown).
(B) Low-concentration Ca2+ area 1 stayed unaltered during the whole imaging period. ((B)-(D): intensity-modulated ratio channel, white; axons, yellow).
(C) High-level Ca2+ area 2 returned to low-level rapidly after MK-801 application.
(D) Strong constant Ca2+ overload indicates ongoing and irreversible neuronal dysfunction, which is also indicated by imminent transsection at 120 min (arrow-
head).
(E) Timeline of Ca2+ dynamics over a period of 90 min after infusion of MK-801. The critical threshold of 45% DR/R as defined by K+Cl application separates
reversible and irreversible axonal Ca2+ dynamics.
(F) Semiquantitative analysis of the reversibility of Ca2+ increase revealed that in B6.tdRFP/B6.Thy1.CertnL15, 75.6% (mean, SEM= 1%) of Ca2+ increase could
be reverted by MK-801 (spontaneous reversibility: mean = 4.1%). Na+ channel blockade in B6.tdRFP/B6.Thy1.CertnL15-active EAE (after 30 min the perfusion
system was changed to a PHT 100 mM solution for 30 min) was with 41.98% reversion, lower compared to MK-801 experiments. (Immune cell motility was not
altered by PHT; data not shown.)
(G) In 2d2.tdRFP Th17 cell-induced adoptive transfer EAE, 64.8% (mean, SEM = 0.6%) were reversible upon MK-801 application compared to a spontaneous
reversibility of 4.15%. Na+ channel blockade by PHT application reverted only 14.18% of Ca2+ increase.
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B6.tdRFP/B6.Thy1.CertnL15 EAE, even 75.64% of Ca2+ was
reversed (Figure 7F). We next asked whether Na+ channel-trig-
gered Ca2+ elevation played a role here. Therefore, we analo-
gously investigated the Na+ channel blocker phenytoin (PHT,
100mM), which was previously shown to reduce axonal damage
in EAE (Lo et al., 2003). Semiquantitative analysis showed here
that in contrast to the blockade of excitotoxicity, only 41.98%
of axonal Ca2+ elevation could be reverted by blocking Na+ chan-
nels in B6.tdRFP/B6.Thy1.CertnL15 (Figure 7F) and in Th17
cell-induced EAE, the reversibility upon Na+ channel blockade
was even lower with only 14.18% reversibility, which indicates
that Th17 cell-induced neuronal damage processes are less
likely to be mediated by Na+ channels. Thus Th17 cell-mediatedImneuronal Ca2+ disturbances were largely reversible by blocking
excitotoxicity whereas a Na+ channel blockade was less
effective.
DISCUSSION
The contribution of the neuronal compartment to MS pathology
has been debated since the first description of the disease and
many theories about the underlying mechanisms have been
generated. Neurobiologists largely emphasize the loss of the
protective myelin sheath and the destruction of the axono-oligo-
dendroglial unit as a decisive cause for (secondary) neuronal
damage, whereas immunologists focus on the inflammatory
milieu as the main factor, inducing bystander damage by meansmunity 33, 424–436, September 24, 2010 ª2010 Elsevier Inc. 433
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Th17 Cell-Induced Neuronal Dysfunctionof cell death-inducing agents, e.g., reactive oxygen species or
cytokines. Here, we propose an alternative way to address
immune-mediated neurodegeneration by highlighting the
specific in vivo interaction between the immune system and
the nervous system, which indicates direct neuronal damage
processes in autoimmune neuroinflammation. We show striking
immune-neuronal synapse formation, which led to severe albeit
potentially reversible neuronal damage processes in the case of
Th17 cells.
By visualizing the immune and neuronal compartment, we
could show that the complexity of immune dynamics, i.e.,
sequential encounters, scanning, and clustering, are much
more diversified in the target organ of a disease, which
exceeds well-described mechanisms of antigen dependent
immune-immune cell interactions (Miller et al., 2002; Kawakami
et al., 2005; Cahalan and Parker, 2006). The somehow unex-
pected attack of Th17 cells on neurons during disease, which
has not been seriously considered to date, revealed a close
interaction of Th17 cells and neurons similar to that seen in
immune synapses or kinapses. Synapses, both the immune
and neuronal subtype, have been shown to ensure a highly
selective signal transduction (Huse et al., 2008). In the immune
synapse, certain soluble factors, including cytolytic molecules
and some cytokines, are secreted in a directional way into
the IS, which prevents collateral damage on neighboring cells
and thus avoids spread of the signal. This leads to highly selec-
tive cytotoxicity of CTL, which earned the figurative title of ‘‘the
kiss of death’’ (Berke, 1995). In conventional ISs, efficient
targeting of granules to the interface requires LFA-1-ICAM-1
interactions (Anikeeva et al., 2005), which is also an essential
mechanism in the Th17 cell-mediated neuronal cell death
induction described here. However, neurons and their pro-
cesses, attacked by T cells during inflammation of the CNS, do
not express MHC-II. In addition, not only CNS-specific
2d2 Th17 cells, but also OT-2 Th17 cells demonstrated a
pronounced propensity to contact axons, which was not as
pronounced with 2d2 Th1 cells. This underlines the idea that
the phenotype of CD4+ T cells was the relevant feature for
immune-mediated neuronal dysfunction and the feature that
made CD4+ T cells open for neuronal or axonal cues that
have yet to be defined. However, the activation status is also
important given that OT-2 Th17 cells did not show as sustained
an effect as 2d2 Th17 cells, most likely because of the lack of
local reactivation. Our results explain the findings of others who
demonstrated that in mice which are deficient in Th17 cell
generation, inflammatory CNS infiltrates can still be found
upon active EAE induction, albeit without a clinically relevant
deficit (Ivanov et al., 2006). Conversely, in another study, the
induction of Th17 cells could be shown to mediate exacerba-
tion in a primarily noninflammatory neurodegenerative Parkin-
son’s disease model (Reynolds et al., 2010).
Concerning the mechanism of killing, straight-forward candi-
dates for the Th17 cells’ cytotoxic potential such as granzyme
B or perforin as classic cytotoxic mediators do not seem to
play an important role because there was no measurable
expression of these mediators in CNS-derived or cultured
Th17 cells in contrast to the non-neurodegenerative Th1 cells.
Here, the Th17 cell phenotype was associated with devastating
neurodegenerative processes and high lethality in B6.Rag1/.434 Immunity 33, 424–436, September 24, 2010 ª2010 Elsevier Inc.Thy1.EGFPmice with adoptive transfer of 2d2.tdRFP Th17 cells.
The role for the cytokines IL-17A and IL-17F themselves as
effector molecules in neuronal injury is highly debated. In an
ischemic stroke model, IL-17A-producing gd T cells could be
shown to increase infarct size in an IL-17-dependent manner
(Shichita et al., 2009), and both IL-17A and the IL-17A receptor
were shown to be upregulated after ischemic brain injury (Wang
et al., 2009). In EAE, both cytokines do not seem to have an
essential role in respect to clinical deficit (Haak et al., 2009),
but these cytokines seem to be reliable markers for the patho-
genic Th17 cell subset in neuroinflammation even if they are
not required. We found here that excitotoxicity was the major
player in these early neuronal damage processes in neuroinflam-
matory lesions given that blockade of NMDA receptors in vivo
dramatically reduced neuronal dysfunction. The amount of
glutamate production in active MS lesions has been correlated
with the extent of axon damage in MS (Werner et al., 2001).
In addition, the presence of receptors for excitatory molecules
has been shown to be upregulated on neurons and/or oligoden-
drocytes (Newcombe et al., 2008; Ouardouz et al., 2009).
However, the mechanisms leading to increased sensitivity
for excitotoxic agents in demyelinating plaques should be
addressed further. Candidate molecules that might be involved
in the sensitization to exitotoxic substances include TRAIL, Fas
and other members of the TNF superfamily. In this context,
it is also important to point out that we investigated neuronal
dysfunction primarily in active demyelinating lesions, which
makes the axono-oligodendroglial unit the actual target. The
fact that the removal of the myelin sheath is incomplete begs
the question of whether the axon and its myelin sheath, which
are inextricable at this point, might be affected differentially.
Nevertheless, the axon was shown to be immediately and
directly affected by the observed immune attack. Our experi-
ments show that immune-mediated (excitotoxic) axonal and
neuronal Ca2+ increase could result in axon dissection and
neuronal soma degeneration. Ca2+ elevation is the earliest sign
of axonal dysfunction, potentially leading to neuronal damage
(Nitsch et al., 2004; McKinney et al., 1999), and involves the
same pathways under a variety of pathophysiologic conditions,
e.g., stroke, traumatic CNS injury or inflammatory CNS disease.
A sustained influx of Ca2+ is sufficient to induce Wallerian
degeneration most likely by means of Ca2+-activated proteases,
which causes cytoskeletal and neurofilamental degradation
(Schlaepfer and Zimmerman, 1985). In line with these findings,
in EAE, a therapeutic blockade of excitotoxic receptors has
been proven to be effective (Pitt et al., 2000; Basso et al.,
2008; Smith et al., 2000).
In summary, once they reach the CNS, activated CD4+ T cells,
in particular, Th17 cells, are able to directly contact neurons as
well as axons and induce Ca2+ changes in an antigen-indepen-
dent manner in these target organ cells. Live-imaging during
disease has characterized the neuronal dysfunction as early
and potentially reversible, which suggests that immune-
mediated disturbances of the neuronal compartment cause
relapsing and remitting disability in patients with multiple scle-
rosis, in addition to conduction blocks as a result of changes
to the myelin sheath. Furthermore, immune-mediated reversible
Ca2+ increase in neurons is a therapeutically accessible dysfunc-
tion of the neuronal compartment.
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Mice
All animals (see also Supplemental Experimental Procedures) were raised
and kept during experiments under SPF conditions in individually ventilated
cages. Bone marrow chimeric mice were generated as described previ-
ously (Siffrin et al., 2009). In brief, recipient animals (B6.Thy1.CertnL15 or
B6.Thy1.EGFP) were lethally irradiated with 1,100 cGy (split dose). Donor
animals were sacrificed by neck dissection; bone marrow cells were isolated
by flushing of femur and tibia, dissolved, and MACS-depleted of CD90+
T cells. Recipients were reconstituted with 12- to 20 3 106 donor bone
marrow cells 8 hr after irradiation. Mice were kept on 0.01% Enrofloxacin
(Baytril, Bayer HealthCare) in drinking water for 4 weeks. Engraftment took
place over 8 weeks of recovery and was checked by FACS analyzing host
PBMC for expression of CD45.2 and tdRFP (more than 95% of CD45.2 cells
[hematopoietic cells] were tdRFP positive). All animal experiments were
approved by local authorities and conducted according to the German Animal
Protection Law.
Experimental Autoimmune Encephalomyelitis
For active EAE, mice were immunized subcutaneously with 150 mg of
MOG35–55 (Pepceuticals, UK) emulsified in complete Freund’s adjuvant
(CFA, BDDifco, Germany). Mice received 200 ng pertussis toxin (PTx, List Bio-
logical Laboratories) intraperitoneally at the time of immunization and 48 hr
later.
For adoptive transfer EAE, spleen cells from B6.2d2 and B6.2d2.tdRFPwere
isolated and a magnetic bead-based cell sort (MACS, Miltenyi Germany) for
the selection of naive CD4+CD62L+ cells was performed in accordance with
the manufacturer’s protocol. CD4+CD62L+ cells were stimulated with myelin
oligodendrocyte glyocoprotein MOG35-55 peptide (12.5 mg/ml MOG35-55;
Pepceuticals) in the presence of irradiated CD90+-depleted C57BL/6 spleen
cells and of 3 ng/ml TGF-b, 20 ng/ml IL-23, and 20 ng/ml IL-6 (all R&D).
Cells were restimulated every week. Three days after the second restimula-
tion, 5 3 106 2d2.tdRFP Th17 cells were transferred intravenously into
B6.Rag1/.Thy1.EGFP (30 3 106 2d2.tdRFP Th17 cells into B6.Thy1.
CertnL15).
Clinical signs of classical (active) EAE were translated into clinical score as
follows: 0, no detectable signs of EAE; 0.5, tail weakness; 1, complete tail
paralysis; 2, partial hind limb paralysis; 2.5, unilateral complete hind limb paral-
ysis; 3, complete bilateral hind limb paralysis; 3.5, complete hind limb paralysis
and partial forelimb paralysis; 4, total paralysis of forelimbs and hind limbs
(mice with a score above 3.5 to be killed); and 5, death. The severity of atypical
(transfer) EAE was translated as follows: grade 1, tail paralysis, hunched
appearance, unsteady walk; grade 2, ataxia, head tilt, hypersensitivity; grade
3, severe ataxia, spasticity or knuckling, severe proprioception defects; and
grade 4, moribund.
T Cell Culture
Spleens from B6.2d2 and B6.OT-2 mice (6–10 weeks old) were isolated and
cultured as described (Siffrin et al., 2009). Th1 cell differentiation was achieved
by the addition of 10 ng/ml IL-12 and 20 mg/ml anti-IL-4 (11B11); for the Th0
phenotype, only 50 U hrIL-2 (Chiron Therapeutics) were added. Cells were
kept in cell culture medium supplemented with hrIL-2 and restimulated
every 7 days (Th17 cells see above). T cells were generally taken on day 3
after second restimulation for coculture or transfer experiments after checking
adequate cytokine expression (Th17 cells: 15%–30% IL-17+, Th1 cells: >50%
IFN-g+).
Cocultures of Neurons and T Cells
Primary cultures of enriched cortical neurons were generated from forebrains
of E17 mice, as described previously (Murphy et al., 2008). A total of 0.5 ml of
the cell suspension containing 500,000 neurons was added into each well on
poly-D-lysine-coated glass slides. Cultures were grown in humidified 5%CO2/
95% air at 37C. Immediately after plating, immunostaining revealed 90%–
95% purity for neurons. Three days after plating, half of the media was
removed and 250 ml fresh media containing 500,000 T cells was added. After
24 hr, cells were fixed with 4% PFA and stained with the relevant antibodies
(see above) or by TUNEL assay.ImIntravital Microscopy
Operation procedures and two-photon laser scanning microscopy were per-
formed as described previously (Siffrin et al., 2009) and are described in detail
in the Supplemental Experimental Procedures.
If mentioned in the experiments, 300 mM MK-801 (Sigma, Germany) or
100 mM Phenytoin (Phenhydan Desitin, Germany) were applied directly to
the open imaging field and washed out with PBS after 60 min. During surgery
andmicroscopy, body temperature wasmaintained at 35C–37C. Anesthesia
depth was controlled by continuous CO2 measurements of exhaled gas and
recorded with a CI-240 Microcapnograph (Columbus Instruments, USA).
The animal experiments were approved by local authorities and were per-
formed in accordance with current guidelines and regulations.
Data Analysis
Images were postprocessed with Volocity (Improvision, Germany) and Imaris
software (Bitplane, Switzerland). False color images of relative Ca2+ concen-
tration were generated with Image J (NIH, USA). Statistical analysis was
carried out with SPSS (SPSS, Germany) and graphical presentation with
GraphPad Prism 5 (GraphPad Software, USA) or Origin (OriginLab Software,
USA).
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